Improved Sprint Performance With Inhaled Long-Acting β2-Agonists Combined With Resistance Exercise

in International Journal of Sports Physiology and Performance
Restricted access

Purchase article

USD  $24.95

Student 1 year subscription

USD  $107.00

1 year subscription

USD  $142.00

Student 2 year subscription

USD  $203.00

2 year subscription

USD  $265.00

Purpose: To investigate the impact of twice-daily inhalation of 100 µg of salmeterol (SAL) or 12 µg of formoterol (FOR) in addition to a strength- and power-training program over a 5-wk period on a 30-m sprint, strength, power, mood, stress, and skinfold thickness. Methods: In a randomized, single-blind study, 23 male and 15 female nonasthmatic, recreationally active individuals were recruited (mean [SD] age 26.3 [5.4] y, weight 76.2 [11.5] kg, height 176.9 [8.5] cm). Participants completed 3 standardized whole-body strength- and power-training sessions per week for 5 wk during which they were assigned to an SAL, FOR, or placebo group. Participants used their inhaler twice per day as instructed and completed assessments of sprint, strength, and power at baseline and 1 wk after cessation of the training program. The assessments included a 30-m sprint, vertical jump, 1-repetition-maximum (1RM) bench press, 1RM leg press, peak torque flexion and extension, anthropometric evaluation, and Rest-Q questionnaires. Results: After 5 wk of strength and power training, 30-m sprint time reduced in the FOR (0.29 [0.11] s, P = .049) and SAL (0.35 [0.05] s, P = .040) groups compared with placebo (+0.01 [0.11] s). No significant change was found in other assessments of strength, mood, or skinfold thickness. Conclusions: When strength and power training are combined with the inhalation of FOR or SAL over a 5-wk period, moderately trained individuals experience an improvement in 30-m sprint performance.

Merlini, Marcora, and Dickinson are with the School of Sport and Exercise Sciences, University of Kent, Chatham Maritime, United Kingdom. Whyte and Chester are with the Research Inst of Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, United Kingdom. Loosemore is with the Inst of Sport, Exercise and Health, University College London, London, United Kingdom.

Merlini (michele.merlini1986@gmail.com) is corresponding author.
  • 1.

    World Anti-Doping Agency. Prohibited list.  https://www.wada-ama.org/sites/default/files/prohibited_list_2019_en.pdf. Accessed January 1, 2019.

    • Export Citation
  • 2.

    Pluim BM, de Hon O, Staal JB, et al. β2-Agonists and physical performance. Sport Med. 2011;41(1):39–57. doi:10.2165/11537540-000000000-00000

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Tjørhom A, Riiser A, Carlsen KH. Effects of formoterol on endurance performance in athletes at an ambient temperature of -20°C. Scand J Med Sci Sports. 2007;17(6):628–635. doi:10.1111/j.1600-0838.2006.00628.x

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Sue-Chu M, Sandsund M, Helgerud J, Reinertsen RE, Bjermer L. Salmeterol and physical performance at -15°C in highly trained nonasthmatic cross-country skiers. Scand J Med Sci Sports. 1999;9(1):48–52. PubMed ID: 9974197. doi:10.1111/j.1600-0838.1999.tb00206.x

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Hostrup M, Kalsen A, Ortenblad N, et al. β2-adrenergic stimulation enhances Ca2+ release and contractile properties of skeletal muscles, and counteracts exercise-induced reductions in Na+-K+-ATPase Vmax in trained men. J Physiol. 2014;592(24):5445–5459. PubMed ID: 25344552. doi:10.1113/jphysiol.2014.277095

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Kalsen A, Hostrup M, Backer V, Bangsbo J. Effect of formoterol, a long-acting β2-adrenergic agonist, on muscle strength and power output, metabolism, and fatigue during maximal sprinting in men. Am J Physiol Regul Integr Comp Physiol. 2016;310(11):R1312–R1321. doi:10.1152/ajpregu.00364.2015

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Sanchez AMJ, Borrani F, Le Fur MA, et al. Acute supra-therapeutic oral terbutaline administration has no ergogenic effect in non-asthmatic athletes. European Journal of Applied Physiol. 2013;113(2):411–418. doi:10.1007/s00421-012-2447-0

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Burniston JG, Clark WA, Tan LB, Goldspink DF. Dose-dependent separation of the hypertrophic and myotoxic effects of the β2-adrenergic receptor agonist clenbuterol in rat striated muscles. Muscle Nerve. 2006;33(5):655–663. PubMed ID: 16411205. doi:10.1002/mus.20504

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Jessen S, Onslev J, Lemminger A, Backer V, Bangsbo J, Hostrup M. Hypertrophic effect of inhaled beta-2-agonist with and without concurrent exercise training: A randomized controlled trial. Scand J Med Sci Sports. 2018;28(10):2114–2122. PubMed ID: 29777633. doi:10.1111/sms.13221

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Lee P, Day RO, Greenfield JR, Ho KKY. Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in men. Int J Obes. 2013;37(4):593–597. doi:10.1038/ijo.2012.90

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Hostrup M, Reitelseder S, Jessen S, et al. Beta2-adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men. J Physiol. 2018;596(17):4121–4139. PubMed ID: 29968301. doi:10.1113/JP275560

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Hostrup M, Kalsen A, Auchenberg M, Bangsbo J, Backer V. Effects of acute and 2-week administration of oral salbutamol on exercise performance and muscle strength in athletes. Scand J Med Sci Sports. 2016;26(1):8–16. PubMed ID: 25077918. doi:10.1111/sms.12298

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Hostrup M, Kalsen A, Onslev J, et al. Mechanisms underlying enhancements in muscle force and power output during maximal cycle ergometer exercise induced by chronic β2-adrenergic stimulation in men. J Appl Physiol 2015;119: 475–486. PubMed ID: 26159759. doi:10.1152/japplphysiol.00319.2015

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Hostrup M, Onslev J, Jacobson GA, Wilson R, Bangsbo J. Chronic β2-adrenoceptor agonist treatment alters muscle proteome and functional adaptations induced by high intensity training in young men. J Physiol. 2018;596(2):231–252. PubMed ID: 28983994. doi:10.1113/JP274970

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Onslev J, Jacobson G, Narkowicz C, et al. Beta-2-adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men. Eur J Appl Physiol. 2017;117(9):1907–1915. PubMed ID: 28702809. doi:10.1007/s00421-017-3679-9

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Yang YT, McElligott MA. Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue. Biochem J. 1989;261(1):1–10. PubMed ID: 2570567. doi:10.1042/bj2610001

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Dickinson J, Hu J, Chester N, Loosemore M, Whyte G. Acute impact of inhaled short acting B2-agonists on 5 km running performance. J Sports Sci Med. 2014;13(2):271–279. PubMed ID: 24790479

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Anderson SD, Argyros GJ, Magnussen H, Holzer K. Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br J Sports Med. 2001;35(5):344–347. PubMed ID: 11579071. doi:10.1136/bjsm.35.5.344

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials. A review. Control Clin Trials. 2002;23(6):662–674. PubMed ID: 12505244. doi:10.1016/S0197-2456(02)00242-8

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Morin JB, Sève P. Sprint running performance: comparison between treadmill and field conditions. Eur J Appl Physiol. 2011;111(8):1695–1703. PubMed ID: 21210279. doi:10.1007/s00421-010-1804-0

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Willardson JM. A brief review: factors affecting the length of the rest interval between resistance exercise sets. J Strength Cond Res. 2006;20(4):978–984. PubMed ID: 17194236.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Baechle TR, Earle RW. Essentials of Strength Training and Conditioning. Champaign, IL: Human Kinetics; 2008.

  • 23.

    Kellmann M. Preventing overtraining in athletes in high-intensity sports and stress/recovery monitoring. Scand J Med Sci Sports. 2010;20(suppl 2):95–102. doi:10.1111/j.1600-0838.2010.01192.x

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Terry PC, Lane AM, Fogarty GJ. Construct validity of the profile of mood states adolescents for use with adults. Psychol Sport Exerc. 2003;4(2):125–139. doi:10.1016/S1469-0292(01)00035-8

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Atkinson G, Nevill AM. Selected issues in the design and analysis of sport performance research. J Sports Sci. 2001;19(10):811–827. PubMed ID: 11561675. doi:10.1080/026404101317015447

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Cohen J. Statistical power analysis. Curr Dir Psychol Sci. 1992;1(3):98–101. doi:10.1111/1467-8721.ep10768783

  • 27.

    Martineau L, Horan MA, Rothwell NJ, Little RA. Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci. 1992;83(5):615–621. PubMed ID: 1335400. doi:10.1042/cs0830615

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    Le Panse B, Collomp K, Portier H, et al. Effects of short-term salbutamol ingestion during a Wingate test. Int J Sports Med. 2005;26(7):518–523. PubMed ID: 16195983. doi:10.1055/s-2004-821224

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29.

    Le Panse B, Arlettaz A, Portier H, Lecoq AM, De Ceaurriz J, Collomp K. Short term salbutamol ingestion and supramaximal exercise in healthy women. Br J Sports Med. 2006;40(7):627–631. PubMed ID: 16687481. doi:10.1136/bjsm.2006.026237

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Hostrup M, Kalsen A, Bangsbo J, Hemmersbach P, Karlsson S, Backer V. High-dose inhaled terbutaline increases muscle strength and enhances maximal sprint performance in trained men. Eur J Appl Physiol. 2014;114:2499–2508. PubMed ID: 25113095. doi:10.1007/s00421-014-2970-2

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31.

    Koch S, Karacabeyli D, Galts C, MacInnis MJ, Sporer BC, Koehle MS. Effects of inhaled bronchodilators on lung function and cycling performance in female athletes with and without exercise-induced bronchoconstriction. J Sci Med Sport. 2015;18(5):607–612. PubMed ID: 25156879. doi:10.1016/j.jsams.2014.07.021

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Dickinson J, Molphy J, Chester N, Loosemore M, Whyte G. The ergogenic effect of long-term use of high dose salbutamol. Clin J Sport Med. 2014;24(6):474–481. PubMed ID: 24451697. doi:10.1097/JSM.0000000000000076

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 58 58 58
Full Text Views 14 14 14
PDF Downloads 9 9 9